ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 274553 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 274553; 2) Community: the network communities that were significantly associated with the response to NSC 274553; 3) Molecule: the relationships between components within communities and NSC 274553; 4) MDR: the compounds that were significantly associated with the NSC 274553.

NSC Compound Enrichment Correlation
NSC 718781 Erlotinib hydrochloride 0.0138010872611486 -0.11113171
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0138010872611486 0.46735974
NSC 726217 Combretastatin A4-analogue 0.0138010872611486 0.1814348
NSC 726578 Null 0.0138010872611486 0.25811871
NSC 729166 N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide 0.0138010872611486 -0.080603296
NSC 730009 cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0138010872611486 0.07110635
NSC 748147 5-methyl-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide 0.0138010872611486 0.25712149
NSC 751042 Null 0.0138010872611486 0.22958465
NSC 756483 SB-742864 0.0138010872611486 0.23350577
NSC 762346 Null 0.0138010872611486 0.023926493
Total:105  Current:44    [First] [Prev] [Next] [Last]